Evidence map›Paper›PMID 41256411›Full record

ArticlebioRxiv : the preprint server for biology2025

High-accuracy SNV calling for bacterial isolates using deep learning with AccuSNV.

Herui Liao, Arolyn Conwill, Ian Light-Maka, Martin Fenk, Alyssa H Mitchell, Evan B Qu, Paul Torrillo, Jacob S Baker, Felix M Key, Tami D Lieberman

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Herui LiaoInstitute for Medical Engineering and Sciences, Massachusetts Institute of Technology; Cambridge, MA 02139, USA.ORCID 0000-0001-8871-3483
Arolyn ConwillInstitute for Medical Engineering and Sciences, Massachusetts Institute of Technology; Cambridge, MA 02139, USA.ORCID 0000-0002-6052-0345
Ian Light-MakaMax Planck Institute for Infection Biology; Berlin 10117, Germany.ORCID 0000-0001-6720-3732
Martin FenkMax Planck Institute for Infection Biology; Berlin 10117, Germany.ORCID 0009-0006-3406-1698
Alyssa H MitchellInstitute for Medical Engineering and Sciences, Massachusetts Institute of Technology; Cambridge, MA 02139, USA.ORCID 0000-0001-8350-2820
Evan B QuInstitute for Medical Engineering and Sciences, Massachusetts Institute of Technology; Cambridge, MA 02139, USA.ORCID 0009-0005-5079-0690
Paul TorrilloInstitute for Medical Engineering and Sciences, Massachusetts Institute of Technology; Cambridge, MA 02139, USA.ORCID 0000-0002-4618-6061
Jacob S BakerInstitute for Medical Engineering and Sciences, Massachusetts Institute of Technology; Cambridge, MA 02139, USA.ORCID 0000-0002-0249-5014
Felix M KeyMax Planck Institute for Infection Biology; Berlin 10117, Germany.ORCID 0000-0003-2812-6636
Tami D LiebermanInstitute for Medical Engineering and Sciences, Massachusetts Institute of Technology; Cambridge, MA 02139, USA.ORCID 0000-0003-1681-2313

Funding

An Evolutionary Framework For Identifying Determinants Of Colonization In Human MicrobiomesDP2GM140922 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LIEBERMAN, TAMI D · 2020 to 2020
$2.3M
Drivers of adaptation and colonization within individual human microbiomesR35GM156282 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Tami D Lieberman · 2025 to 2026
$1.1M
NIGMS NIH HHS DP2 GM140922NIGMS NIH HHS R35 GM156282
6 · The paper itself

Abstract

Accurate detection of mutations within bacterial species is critical for fundamental studies of microbial evolution, reconstructing transmission events, and identifying antimicrobial resistance mutations. While many tools have been developed to identify single nucleotide variants (SNVs) from whole-genome sequencing, they often suffer from high false positive rates due to the complexity of bacterial genomes and the need for different filtering cutoffs across sample types and sequencing depths. As datasets increase in size, the manual filtering required for high accuracy presents a significant obstacle. Here, we present AccuSNV, a novel deep learning-based tool for high-precision and automated bacterial SNV calling. Unlike traditional methods that process one sample at a time, AccuSNV leverages a convolutional neural network (CNN) that integrates alignment information across multiple samples, enhancing precision through learned across-sample patterns. We evaluated AccuSNV against seven popular SNV calling tools using simulated data from six bacterial species with varied sequencing depths, numbers of isolates, mutations, and divergence levels. To further validate its real-world utility, we tested AccuSNV on multiple curated bacterial datasets containing reported SNVs. In both simulated and real-world scenarios, AccuSNV consistently achieved the best performance. Moreover, AccuSNV provides comprehensive user-friendly downstream analysis modules and outputs, including mutation annotation information, phylogenetic inference, dN/dS calculations, and optional manual filtering. Together with the automated deep learning-based calling, these features make AccuSNV broadly accessible to users with different levels of computational expertise.

Identifiers

PMID41256411
PMCPMC12622049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.